Skip to main navigation
Skip to search
Skip to main content
PolyU Scholars Hub Home
Help & FAQ
Link opens in a new tab
Search content at PolyU Scholars Hub
Home
Researchers
Units
Research output
Prizes
Activities
Press/Media
Student theses
Engineering botulinum neurotoxin to extend therapeutic intervention
Sheng Chen
, Joseph T. Barbieri
Research output
:
Journal article publication
›
Journal article
›
Academic research
›
peer-review
73
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Engineering botulinum neurotoxin to extend therapeutic intervention'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Botulinum Neurotoxin (BoNT)
100%
Therapeutic Intervention
100%
SNAP23
80%
Non-neuronal
80%
SNARE Proteins
60%
Soluble N-ethylmaleimide-sensitive Factor Attachment Protein Receptor (SNARE)
40%
Catalytic Activity
20%
Therapeutic Potential
20%
Plasma Membrane
20%
Strabismus
20%
Light Chain
20%
Insulin
20%
Membrane Fusion
20%
Neurological Disorders
20%
Retargeting
20%
Therapeutic Use
20%
SNAP-25
20%
Botulinum Neurotoxin E
20%
Substrate Specificity
20%
Fusion Process
20%
Interleukin-8
20%
Cervical Dystonia
20%
Direct Protein Delivery
20%
Spasm
20%
Clostridium Botulinum
20%
Tropism
20%
Human Epithelial Cells
20%
Mucin
20%
Natural Substrate
20%
SNAP47
20%
SNAP29
20%
Hypersecretion
20%
Gastric Acid
20%
Airway mucus
20%
Non-neuronal Cells
20%
Medicine and Dentistry
Clostridium Botulinum Type A
100%
SNARE (Protein)
60%
Secretion (Process)
40%
Cleft
40%
Strabismus
20%
Cell Membrane
20%
Epithelial Cell
20%
Light Chain
20%
Mucus
20%
Receptor Protein
20%
Spasmodic torticollis
20%
Enzyme Specificity
20%
Botulinum Toxin E
20%
Synaptosomal Associated Protein 25
20%
Insulin Antibody
20%
Mucin
20%
N Ethylmaleimide
20%
Membrane Fusion
20%
Clostridium botulinum
20%
Muscle Spasm
20%
Nervous System Disorder
20%
Chimeric Protein
20%
Diseases
20%
Neuroscience
Clostridium Botulinum Type A
100%
SNARE (Protein)
50%
Cleft
33%
Epithelial Cells
16%
Nervous System Disorder
16%
Light Chain
16%
N-Ethylmaleimide
16%
Synaptosomal Associated Protein 25
16%
Enzyme Specificity
16%
Membrane Fusion
16%
Insulin Antibody
16%
Receptor Protein
16%
Strabismus
16%
Cell Membrane
16%
Spasmodic torticollis
16%
Mucin
16%
Chimeric Protein
16%
Interleukin 8
16%
Clostridium botulinum
16%
Pharmacology, Toxicology and Pharmaceutical Science
Clostridium Botulinum Type A
100%
SNARE Protein
60%
Protein Delivery
20%
Substrate Specificity
20%
Receptor Protein
20%
Cervical Dystonia
20%
Insulin Antibody
20%
Botulinum Toxin E
20%
Mucin
20%
N Ethylmaleimide
20%
Clostridium botulinum
20%
Muscle Spasm
20%
Strabismus
20%
Synaptosomal Associated Protein 25
20%
Chimeric Protein
20%
Diseases
20%